Abata Therapeutics logo

Abata Therapeutics

Cambridge, MA

Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases.

abatatx.com

Company Details

Founded

2021

Employees

Between 20 - 100 employees

Raised

$95,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Samantha SingerSamantha Singer

Founders

Richard Ransohoff
Richard Ransohoff

Company Collections

These are collections Abata Therapeutics is a part of. Click on the collection name to view similar companies.

Abata Therapeutics' Investors

Abata Therapeutics' Industries

Abata Therapeutics' Tech Stack

Abata Therapeutics Headquarters Location

245 First Street, Cambridge, MA 02142

Total Amount Raised: $95,000,000

Abata Therapeutics' Investors

Abata Therapeutics Funding Rounds

  • Series A

    $95,000,000

    Series A Investors

    Third Rock Ventures
    ElevateBio
    Invus Group
    Lightspeed Venture Partners
    JDRF T1D Fund
    Samsara BioCapital
    Eurofarma Ventures
Funding info provided by Diffbot.

Abata Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Abata Therapeutics.

Recent reviews